eurycomanol

RN given for (1beta,2alpha,11beta,12alpha,15beta)-isomer; quassinoid isolated from Eurycoma longifolia

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Bao, Ruixia: 1 article (02/2022)
2.	Chen, Qian: 1 article (02/2022)
3.	Li, Zheng: 1 article (02/2022)
4.	Liu, Mengyang: 1 article (02/2022)
5.	Wang, Dan: 1 article (02/2022)
6.	Wang, Tao: 1 article (02/2022)
7.	Wu, Yuzheng: 1 article (02/2022)
8.	Zhang, Yi: 1 article (02/2022)
9.	Chateauvieux, Sébastien: 1 article (09/2014)
10.	Choo, Chee-Yan: 1 article (09/2014)

1.	Lung Neoplasms (Lung Cancer) 06/01/2023 - "Eurycomanol and eurycomanone as potent inducers for cell-cycle arrest and apoptosis in small and large human lung cancer cell lines." 06/01/2023 - "This study evaluated the anticancer, cell-cycle arrest, and apoptotic induction potentials of eurycomanone (EONE) and eurycomanol (EOL), highly oxygenated quassinoids previously isolated from its roots, against large (H460) and small (A549) lung cancer cells. "
2.	Hyperuricemia 02/01/2022 - "longifolia can promote UA excretion through kidney and intestine, decrease hepatic purine synthesis and further keep UA homeostasis, suggesting that eurycomanol has the potential to be developed into a novel drug for the treatment of under-excretion type hyperuricemia." 02/01/2022 - "Eurycomanol alleviates hyperuricemia by promoting uric acid excretion and reducing purine synthesis."
3.	Inflammation (Inflammations) 09/16/2014 - "Eurycomanone and eurycomanol from Eurycoma longifolia Jack as regulators of signaling pathways involved in proliferation, cell death and inflammation."